Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conferences:

Conference Years:

Days Within Meeting:

Has CME:

Do I Have Access?

Access:

Availability:

Participation Type:

Categories:

Therapeutic Trials and Prognostic Markers for Adrenal Diseases

Browse by: Sort by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 1 of 1
Chair
Katja Kiseljak-Vassiliades, DO
University of Colorado Denver, Aurora, CO
Results of the ADIUVO Study, the First Randomized Trial on Adjuvant Mitotane in Adrenocortical Carcinoma Patients
Massimo Terzolo, MD
University of Turin San Luigi Hospital, Orbassano, Italy
Audience Q&A
Modified GRAS Score for Prognostic Classification of Adrenocortical Carcinoma: An ENSAT Multicentre Study
Yasir Elhassan, MD
University of Birmingham, Birmingham, United Kingdom
Audience Q&A
Biochemical Tumor Marker Status and Its Role in Treatment Response in Patients Who Received High-Specific-Activity I-131 MIBG in Advanced Pheochromocytoma and Paraganglioma (PPGL): Results From a Pivotal Phase 2 Clinical Trial
Camilo Jimenez, MD
UT MD Anderson Cancer Center, Houston, TX
Audience Q&A
Mortality and Specific Causes of Death in Endogenous Cushing’s Syndrome: A Systematic Review, Meta-Analysis and Meta-Regression
Padiporn Limumpornpetch, Endocrinologist
University of Leeds, Leeds, United Kingdom
Audience Q&A
from ENDO 2021 on March 20, 2021 2:15 PM-3:15 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 1 of 1